Scaling Cell & Gene Therapies: From Breakthroughs to the Mass Market
Manage episode 505632816 series 2994360
In this two-part series, host Stuart Lowe examines the barriers and breakthroughs that will determine whether cell and gene therapies can scale. From smarter manufacturing to new policy frameworks, join leading experts as they discuss what must change for CGTs to deliver on their full potential.
30 episodes